India Stocks: Fund Manager Prashant Khemka Says NOW is the Time to Buy - Here's Why!
Overview
Prashant Khemka, Founder of WhiteOak Capital Group, suggests Indian equity markets offer a comfortable entry point after a year of muted returns. He notes current valuations are near long-term averages, making risk-reward favourable. Despite competition from AI-driven markets like South Korea and China, Khemka believes India's resilience in tech cycles positions it well. He anticipates low double-digit earnings growth and sees opportunities in financial services, especially areas facing peak pessimism, and in the healthcare sector.
India Stocks Presenting Attractive Entry Point, Says WhiteOak Capital Founder
Despite a period of muted returns over the past year, Indian equity markets are presenting investors with a significantly more attractive entry point, according to Prashant Khemka, Founder of WhiteOak Capital Group. The firm manages approximately $10.8 billion in assets. Khemka stated that the Indian market is currently trading close to its long-term average valuation, offering a more favourable risk-reward balance after an extended phase of sideways movement.
He highlighted that the market has remained relatively flat for about 15 months, trading approximately 5% below its peak. This current juncture, he believes, is more opportune for deploying fresh capital compared to most of the preceding year. This perspective comes as India faces increased competition for global investment funds, particularly from markets benefiting from the artificial intelligence boom.
The Core Issue
Prashant Khemka addressed the recent performance of Indian equities, which have lagged emerging market peers by nearly 30% in 2024. This underperformance has led some investors to question India's appeal, especially when contrasted with high-flying markets driven by artificial intelligence themes like South Korea and China. Khemka acknowledged the competitive landscape but drew parallels to India's historical investment cycles.
He pointed out that India was not an early adopter of the dot-com boom or the mobile revolution, yet it emerged as the top-performing emerging market over the last 25 years. This historical pattern suggests India often benefits from being a follower rather than a first mover in technology trends.
Financial Implications
Khemka suggested that a potential correction in the global AI trade could unexpectedly benefit India due to its comparatively lower exposure to this specific theme. This could shift investor focus back to markets offering stable growth prospects. Regarding earnings, he noted a slowdown to mid-single-digit growth over the last 12 to 18 months. However, he contextualized this as a reversion to the trend after a strong post-COVID surge. Khemka projects a return to low double-digit earnings growth over the next three to five years, aligning with historical nominal GDP growth, which should be reflected in market returns.
Sector Focus: Financials
Financial services remain the largest allocation in WhiteOak Capital Group's portfolios. Khemka identified this sector as currently experiencing peak pessimism, particularly in segments like unsecured lending and microfinance. He views this widespread negativity as a potential catalyst for investment opportunities. He indicated that asset quality stress is likely nearing its peak, with expectations for improvement going forward. The struggles of several Non-Banking Financial Company (NBFC) initial public offerings this year suggest that negative sentiment towards the sector may already be priced into its valuations.
Khemka believes Indian financials now offer a compelling mix of compressed valuations, robust asset quality, and steady growth compared to peers in other emerging markets.
Sector Focus: Healthcare
Beyond financials, Khemka highlighted the healthcare sector as a source of attractive long-term investment opportunities, though it often remains overlooked. He described it as a complex sector that does not typically experience hyper-growth, which keeps it out of the spotlight. WhiteOak Capital Group holds an overweight position in pharmaceuticals, hospitals, diagnostics, and Contract Development and Manufacturing Organization (CDMO) businesses. While these sectors offer long-term potential, financials continue to be the largest holding due to their significant weight in the broader Indian market.
Impact
This analysis could encourage investors to reconsider their allocation to Indian equities, potentially leading to increased capital inflows. The positive outlook on valuations and specific sectors might stimulate buying interest, influencing market sentiment and potentially boosting stock prices in the financial and healthcare industries. The advice from a prominent fund manager like Prashant Khemka often carries weight, potentially influencing individual and institutional investment decisions.
Impact rating: 8
Difficult Terms Explained
- Valuations: The process of determining the current worth of an asset or a company.
- Risk-Reward: The potential return on an investment relative to the risk taken.
- P/E (Price-to-Earnings) Ratio: A valuation ratio of a company's share price to its earnings per share.
- Nominal GDP Growth: The growth in the value of goods and services produced in an economy, not adjusted for inflation.
- NBFCs (Non-Banking Financial Companies): Financial institutions that provide banking-like services but do not hold a banking license.
- Asset Quality: Refers to the credit risk associated with a financial institution's assets, particularly its loan portfolio.
- CDMO (Contract Development and Manufacturing Organization): A company that offers drug development and manufacturing services to other pharmaceutical companies.
